FEDERATED HERMES, INC.
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1056288
PITTSBURGH, PA
Position in ARCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$22,200,460
-$3,303,640 QoQ
Shares Held
3,303,640
0.0% QoQ
Ownership
11.6%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1
of 133 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ARCT ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in ARCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,200,460 | 3,303,640 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $25,504,100 | 3,303,640 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $20,251,313 | 3,303,640 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $86,511,525 | 4,694,060 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $61,069,720 | 4,694,060 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $49,710,095 | 4,694,060 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $79,658,198 | 4,694,060 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $108,949,132 | 4,694,060 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $114,300,361 | 4,694,060 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $158,562,712 | 4,695,372 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $148,553,973 | 4,711,512 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $120,379,131 | 4,711,512 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $137,047,380 | 4,778,500 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $114,540,645 | 4,778,500 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $71,902,835 | 4,239,554 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $52,870,305 | 3,567,497 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,051,666 | 3,561,097 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $101,420,824 | 3,761,900 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $136,749,322 | 3,694,929 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $145,503,860 | 3,045,288 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $102,467,520 | 3,028,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $132,283,900 | 3,203,000 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $149,782,897 | 3,452,810 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $59,059,357 | 1,376,675 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $28,747,156 | 615,044 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||